Vera Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2016-01-01
- Employees
- 51
- Market Cap
- $2B
- Website
- http://www.veratx.com
- Introduction
Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.
Atacicept in Multiple Glomerular Diseases
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Vera Therapeutics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06983028
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept
Phase 2
- Conditions
- IgA Nephropathy (IgAN)Renal and Urinary DisordersBerger Disease
- Interventions
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Vera Therapeutics, Inc.
- Target Recruit Count
- 476
- Registration Number
- NCT06674577
- Locations
- 🇺🇸
Vera Therapeutics, Brisbane, California, United States
Atacicept in Subjects With Active Lupus Nephritis (COMPASS)
- First Posted Date
- 2022-11-08
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Vera Therapeutics, Inc.
- Target Recruit Count
- 360
- Registration Number
- NCT05609812
- Locations
- 🇺🇸
Vera Site # 0131, Torrance, California, United States
🇺🇸Vera Site # 0125, Dallas, Texas, United States
🇺🇸Vera Site # 0128, Miami, Florida, United States
Atacicept in Subjects With IgA Nephropathy
Phase 3
Active, not recruiting
- Conditions
- IgA NephropathyBerger Disease
- Interventions
- Other: Placebo to match Atacicept
- First Posted Date
- 2021-01-20
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Vera Therapeutics, Inc.
- Target Recruit Count
- 376
- Registration Number
- NCT04716231
- Locations
- 🇺🇸
ORIGIN 3 Global Site Contact Information, Brisbane, California, United States
A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients
- First Posted Date
- 2020-03-04
- Last Posted Date
- 2023-06-07
- Lead Sponsor
- Vera Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04294472
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸University of Washington, Seattle, Washington, United States
🇺🇸University of Kentucky, Lexington, Kentucky, United States
© Copyright 2025. All Rights Reserved by MedPath